Unidade Local de Saude de Santa Maria
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lopes, Ana Beatriz S
DEFENDER, NCT05558098: Dapagliflozin in Patients With Critical Illness

Completed
3
507
RoW
Dapagliflozin 10mg Tab, Farxiga, Standard of Care
Hospital Israelita Albert Einstein
Critical Illness, Sepsis
10/23
10/23
AMAY, NCT05509777 / 2022-000811-29: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Recruiting
3
90
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company, Eli Lilly and Company
Crohn's Disease
07/27
10/27
STRIDES, NCT05490563: - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia

Terminated
2/3
23
Europe, US, RoW
SLS-005, Placebo
Seelos Therapeutics, Inc.
Spinocerebellar Ataxia Type 3
11/23
11/23
CAR-CF, NCT06274840: COVID-19 Antibody Responses In Cystic Fibrosis

Recruiting
N/A
1000
Europe
Pilar Azevedo, Queen's University, Belfast, European Cystic Fibrosis Society - Clinical Trial Network, Cystic Fibrosis Foundation, Medical University Innsbruck
COVID-19, Cystic Fibrosis
09/25
09/25
ELAN, NCT03148457: Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Completed
N/A
2013
Europe, Japan, RoW
Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®), Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Insel Gruppe AG, University Hospital Bern
Ischaemic Stroke
12/22
05/23
TASTY, NCT06758817: The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis

Recruiting
N/A
100
Europe
MedDiet+ intervention, General dietary recommendations
Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa, Gulbenkian Institute for Molecular Medicine
Diet Interventions
09/25
12/25
NCT05430412: CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis

Recruiting
N/A
15
Europe
Adacolumn
Adacyte Therapeutics SL, Adknoma Health Research
Ulcerative Colitis
10/24
10/24

Download Options